Litcius/Paper detail

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

Alessandro Mantovani, Christopher D. Byrne, Eleonora Scorletti, Christos S. Mantzoros, Giovanni Targher

2020Diabetes & Metabolism140 citationsDOIOpen Access PDF

Topics & Concepts

PioglitazoneMedicineMetforminFatty liverLiraglutideInternal medicineSteatohepatitisGastroenterologyDiabetes mellitusType 2 diabetesRandomized controlled trialInsulin resistanceThiazolidinedioneCombination therapyEndocrinologyDiseaseInsulinLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials | Litcius